14–3-3 eta (η) protein as a promising marker for rheumatoid arthritis: relation to joint damage and subclinical atherosclerosis
Abstract Background Accelerated atherosclerosis is a common health insult in rheumatoid arthritis (RA) patients. Pro-inflammatory cytokines, endothelial dysfunction, and autoantibodies participate in the progression of RA-related atherosclerosis. Novel biomarkers may help early detection of subclini...
Saved in:
| Main Authors: | Sahar A. Elsayed, Doaa Adel, Mohammed Zaki, Eman A. M. Alkady |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-03-01
|
| Series: | Egyptian Rheumatology and Rehabilitation |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43166-025-00311-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of 14-3-3 η eta protein in juvenile idiopathic arthritis
by: Khaled Omar Elfarouk Zaiton, et al.
Published: (2025-06-01) -
The 14-3-3η Biomarker Platform for Diagnosis and Prognostic Monitoring of Patients with Rheumatoid Arthritis
by: W. Maksymowych
Published: (2024-03-01) -
Study of rheumatoid arthritis in older patients: a cross-sectional study
by: Ramesh Kumar Sah, et al.
Published: (2025-07-01) -
The Efficacy of Kinetotherapy in Larsen Syndrome in Children
by: Iulian ICLEANU
Published: (2025-05-01) -
η-Intuitionistic Fuzzy Soft Groups
by: Mustika Ana Kurfia, et al.
Published: (2022-10-01)